Abbreviated Injury Scale other than head >3.Physician plan to start/restart antiplatelet therapy during trial period.SDH >8 mm maximum width or any midline shift at any time point or more than one SDH.Mechanical Valve or Ventricular Assist Device (VAD).
DOAC at continuation dose, i.e., not initial therapy high doses in the setting of VTE DOAC prescribed at label dose with creatinine clearance adjustments.Patient is higher risk for stroke or other thrombotic events as witnessed by having a CHA2DS2-VASc score of > 3 (at least 3 of the following risk factors: age greater than 65, (age > 75 counts for 2 points), history of stroke or TIA (2 points), history of heart failure, history of diabetes, history of atherosclerotic vascular disease, female biological sex, history of hypertension).Acute traumatic intracranial hemorrhage on anticoagulation for Atrial Fibrillation (AF) or Venous Thromboembolism (VTE).Why Should I Register and Submit Results?.
0 kommentar(er)
